We describe how BLM treatment induces an immunogenic apoptosis of tumor cells, anti-tumor CD8+ T cell response and the production of the tolerogenic cytokine transforming growth factor beta (TGFβ) by tumor cells which mediates regulatory T cell accumulation in vivo. The gene discussed is CD8A; the disease is neoplasm.